InvivoGen
PC-61.5.3-derived monoclonal antibody against murine CD25 (blocking)
InvivoGen
InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables them to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
More information at https://www.invivogen.com.
InvivoGen
7D4-derived monoclonal antibody against murine CD25 (non-blocking)
InvivoGen
YTS 169.4-derived mouse monoclonal antibody against murine CD8α
InvivoGen
RMP1-14-derived mouse monoclonal antibody against murine PD-1
InvivoGen
Dual IRF and IFN-β reporter 293 cells expressing A162 isoform of human STING (S162A)
InvivoGen
Dual IRF and IFN-β reporter 293 cells expressing H232 isoform of human STING (R232H)
InvivoGen
Dual IRF and IFN-β reporter 293 cells expressing R232 isoform of human STING
